# EDGAR Filing Document

**Accession Number:** 0002009347
**File Stem:** 0001590714-26-000011
**Filing Date:** 2026-2
**Character Count:** 9264
**Document Hash:** df60c8d9183b6592aad42b1b7d9f34ab
**Contains OCR:** False
**Source Format:** 

## Filing Content

## Filing Summary
**0001590714-26-000011.hdr.sgml**: 20260212

**ACCESSION NUMBER**: 0001590714-26-000011

**CONFORMED SUBMISSION TYPE**: 4

**PUBLIC DOCUMENT COUNT**: 1

**CONFORMED PERIOD OF REPORT**: 20260210

**FILED AS OF DATE**: 20260212

**DATE AS OF CHANGE**: 20260212

**REPORTING-OWNER**: 

**OWNER DATA:**
- **COMPANY CONFORMED NAME:** Liebowitz Matthew
- **CENTRAL INDEX KEY:** 0002009347

**ORGANIZATION NAME:**

**FILING VALUES:**
- **FORM TYPE:** 4
- **SEC ACT:** 1934 Act
- **SEC FILE NUMBER:** 001-36272
- **FILM NUMBER:** 26626939

**MAIL ADDRESS:**
- **STREET 1:** 383 MAIN AVENUE, 6TH FLOOR
- **CITY:** NORWALK
- **STATE:** CT
- **ZIP:** 06851
**ISSUER**: 

**COMPANY DATA:**
- **COMPANY CONFORMED NAME:** Element Solutions Inc
- **CENTRAL INDEX KEY:** 0001590714
- **STANDARD INDUSTRIAL CLASSIFICATION:** MISCELLANEOUS CHEMICAL PRODUCTS [2890]
- **ORGANIZATION NAME:** 08 Industrial Applications and Services
- **EIN:** 371744899
- **FISCAL YEAR END:** 1231

**BUSINESS ADDRESS:**
- **STREET 1:** 500 S POINTE DRIVE
- **STREET 2:** SUITE 200
- **CITY:** MIAMI BEACH
- **STATE:** FL
- **ZIP:** 33139
- **BUSINESS PHONE:** 561-207-9600

**MAIL ADDRESS:**
- **STREET 1:** 500 S POINTE DRIVE
- **STREET 2:** SUITE 200
- **CITY:** MIAMI BEACH
- **STATE:** FL
- **ZIP:** 33139

**FORMER COMPANY:**
- **FORMER CONFORMED NAME:** Platform Specialty Products Corp
- **DATE OF NAME CHANGE:** 20131031

### UNITED STATES SECURITIES AND EXCHANGE COMMISSION
**Washington, D.C. 20549**

## FORM 4

### STATEMENT OF CHANGES IN BENEFICIAL OWNERSHIP

[ ] Check this box if no longer subject to Section 16. Form 4 or Form 5 obligations may continue. See Instruction 1(b).

[ ] Check this box to indicate that a transaction was made pursuant to a contract, instruction or written plan for the purchase or sale of equity securities of the issuer that is intended to satisfy the affirmative defense conditions of Rule 10b5-1(c). See Instruction 10.

---

| | | |
|:---|:---|:---|
| **1. Name and Address of Reporting Person**<sup>*</sup><br>Liebowitz Matthew<br><sub>(Last) (First) (Middle)</sub><br>C/O ELEMENT SOLUTIONS INC<br>500 S POINTE DRIVE, SUITE 200<br><sub>(Street)</sub><br>MIAMI BEACH, FL 33139<br><sub>(City) (State) (Zip)</sub> | **3. Date of Earliest Transaction (Month/Day/Year)**<br>2026-02-10 | **5. Relationship of Reporting Person(s) to Issuer**<br>(Check all applicable)<br>[ ] Director [ ] 10% Owner<br>[X] Officer (give title below) [ ] Other (specify below)<br>_President, Specialties_ |
| **2. Issuer Name and Ticker or Trading Symbol**<br>Element Solutions Inc [ ESI ] | **4. If Amendment, Date of Original Filed (Month/Day/Year)**<br>  | **6. Individual or Joint/Group Filing (Check Applicable Line)**<br>[X] Form filed by One Reporting Person<br>[ ] Form filed by More than One Reporting Person |

---

## Table I - Non-Derivative Securities

---

|  |  |  |  |  |  |  |  |  |  |  |
| --- | --- | --- | --- | --- | --- | --- | --- | --- | --- | --- |
| 1. Title of Security | 2. Transaction Date | 2A. Deemed Execution Date | 3. Transaction Code (V) | 3. Transaction Code (V) | 4. Securities Acquired (A) or Disposed of (D) | 4. Securities Acquired (A) or Disposed of (D) | 4. Securities Acquired (A) or Disposed of (D) | 5. Amount of Securities Beneficially Owned | 6. Ownership Form | 7. Nature of Indirect Beneficial Ownership |
| 1. Title of Security | 2. Transaction Date | 2A. Deemed Execution Date | Code | V | Amount | (A) or (D) | Price | 5. Amount of Securities Beneficially Owned | 6. Ownership Form | 7. Nature of Indirect Beneficial Ownership |
| Common Stock, par value $0.01 per share | 2026-02-10 |  | M |  | 27166 | A | <sup>(1)</sup> | 144559 | D |  |
| Common Stock, par value $0.01 per share | 2026-02-11 |  | F |  | 10336<sup>(2)</sup> | D | $31.97 | 134223 | D |  |
| Common Stock, par value $0.01 per share | 2026-02-10 |  | M |  | 3353 | A | <sup>(3)</sup> | 137576 | D |  |
| Common Stock, par value $0.01 per share | 2026-02-11 |  | F |  | 1427<sup>(4)</sup> | D | $31.97 | 136149 | D |  |
| Common Stock, par value $0.01 per share | 2026-02-10 |  | M |  | 4222 | A | <sup>(5)</sup> | 140371 | D |  |
| Common Stock, par value $0.01 per share | 2026-02-11 |  | F |  | 1607<sup>(6)</sup> | D | $31.97 | 138764 | D |  |
| Common Stock, par value $0.01 per share | 2026-02-10 |  | M |  | 3875 | A | <sup>(7)</sup> | 142639 | D |  |
| Common Stock, par value $0.01 per share | 2026-02-11 |  | F |  | 1475<sup>(8)</sup> | D | $31.97 | 141164 | D |  |

---

## Table II - Derivative Securities

---

|  |  |  |  |  |  |  |  |  |  |  |  |  |  |  |  |
| --- | --- | --- | --- | --- | --- | --- | --- | --- | --- | --- | --- | --- | --- | --- | --- |
| 1. Title of Derivative Security | 2. Conversion or Exercise Price | 3. Transaction Date | 3A. Deemed Execution Date | 4. Transaction Code (V) | 4. Transaction Code (V) | 5. Number of Derivative Securities Acquired (A) or Disposed of (D) | 5. Number of Derivative Securities Acquired (A) or Disposed of (D) | 6. Date Exercisable and Expiration Date | 6. Date Exercisable and Expiration Date | 7. Title and Amount of Underlying Securities | 7. Title and Amount of Underlying Securities | 8. Price of Derivative Security | 9. Number of Derivative Securities Beneficially Owned | 10. Ownership Form | 11. Nature of Indirect Beneficial Ownership |
| 1. Title of Derivative Security | 2. Conversion or Exercise Price | 3. Transaction Date | 3A. Deemed Execution Date | Code | V | (A) | (D) | Date Exercisable | Expiration Date | Title | Amount or Number of Shares | 8. Price of Derivative Security | 9. Number of Derivative Securities Beneficially Owned | 10. Ownership Form | 11. Nature of Indirect Beneficial Ownership |
| Performance Stock Units | $0 | 2026-02-10 |  | M |  |  | 20122 | <sup>(1)</sup> | <sup>(1)</sup> | Common Stock | 27166 | <sup>(1)</sup> | 0 | D |  |
| Restricted Stock Units | $0 | 2026-02-10 |  | M |  |  | 3353 | <sup>(3)</sup> | <sup>(3)</sup> | Common Stock | 3353 | <sup>(3)</sup> | 0 | D |  |
| Restricted Stock Units | $0 | 2026-02-10 |  | M |  |  | 4222 | <sup>(5)</sup> | <sup>(5)</sup> | Common Stock | 4222 | <sup>(5)</sup> | 4221 | D |  |
| Restricted Stock Units | $0 | 2026-02-10 |  | M |  |  | 3875 | <sup>(7)</sup> | <sup>(7)</sup> | Common Stock | 3875 | <sup>(7)</sup> | 7748 | D |  |
| Performance Stock Units | $0 | 2026-02-10 |  | A |  | 37745 |  | <sup>(9)</sup> | <sup>(9)</sup> | Common Stock | 37745 | <sup>(9)</sup> | 37745 | D |  |
| Restricted Stock Units | $0 | 2026-02-10 |  | A |  | 18871 |  | <sup>(10)</sup> | <sup>(10)</sup> | Common Stock | 18871 | <sup>(10)</sup> | 18871 | D |  |

---

### Footnotes:

(1) Represents settlement of a performance restricted stock unit ("PRSU") award previously reported in 2023. Each PRSU represented a contingent right to receive up to two shares of the Issuer's common stock.

(2) Represents disposed shares to cover tax withholdings due upon vesting of the PRSUs described in footnote 1.

(3) Represents settlement of 1/3 of a restricted stock unit ("RSUs") award previously reported in 2023. Each RSU represented a contingent right to receive one share of the Issuer's common stock.

(4) Represents disposed shares to cover tax withholdings due upon vesting of the RSUs described in footnote 3.

(5) Represents settlement of 1/3 of a RSU award previously reported in 2024. Each RSU represented a contingent right to receive one share of the Issuer's common stock.

(6) Represents disposed shares to cover tax withholdings due upon vesting of the RSUs described in footnote 5.

(7) Represents settlement of 1/3 of a RSU award previously reported in 2025. Each RSU represented a contingent right to receive one share of the Issuer's common stock.

(8) Represents disposed shares to cover tax withholdings due upon vesting of the RSUs described in footnote 7.

(9) Each PRSU represents a contingent right to receive up to three shares of the Issuer's common stock, subject to the achievement of certain adjusted EBITDA compound annual growth and adjusted earnings per share goals for the performance period ending on December 31, 2028 and a relative total shareholder return (TSR) modifier based on the Issuer's TSR in comparison to its peer group for that same period. The number of shares reported in column 7 will range from zero to 113,235 shares.

(10) Each RSU represents a contingent right to receive one share of the Issuer's common stock. The grant will vest in 1/3 increments over the next three years.

**Signature:** /s/ Caroline S. Lind as Attorney-in-Fact for Matthew Liebowitz  
**Date:** 2026-02-12

### Remarks:

Reminder: Report on a separate line for each class of securities beneficially owned directly or indirectly.

* If the form is filed by more than one reporting person, see Instruction 4 (b)(v).

** Intentional misstatements or omissions of facts constitute Federal Criminal Violations See 18 U.S.C. 1001 and 15 U.S.C. 78ff(a).

Note: File three copies of this Form, one of which must be manually signed. If space is insufficient, see Instruction 6 for procedure.

**Persons who respond to the collection of information contained in this form are not required to respond unless the form displays a currently valid OMB Number.**